Submission Details
| 510(k) Number | K234151 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 29, 2023 |
| Decision Date | August 27, 2024 |
| Days to Decision | 242 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K234151 is an FDA 510(k) clearance for the Isolator Synergy EnCapture Ablation System (EMH), a Surgical Device, For Cutting, Coagulation, And/or Ablation Of Tissue, Including Cardiac Tissue (Class II — Special Controls, product code OCL), submitted by AtriCure, Inc. (West Chester, US). The FDA issued a Cleared decision on August 27, 2024, 242 days after receiving the submission on December 29, 2023. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 878.4400.
| 510(k) Number | K234151 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 29, 2023 |
| Decision Date | August 27, 2024 |
| Days to Decision | 242 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | OCL — Surgical Device, For Cutting, Coagulation, And/or Ablation Of Tissue, Including Cardiac Tissue |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 878.4400 |
| Definition | Surgical Device For Cutting, Coagulation, And/or Ablation Of Tissue, Including Cardiac Tissue |